Skip to main content
Close
Home
Presented by
  • MDedge
Home
Full Menu Full Menu
  • Clinical Edge Journal Scan
  • Clinical Topics
  • Conference Coverage
  • Expert Perspectives
  • MD-IQ

Clinical Topics

August 29, 2022

‘Molecular map’ of CLL yields fresh genetic insights

August 29, 2022
Randy Dotinga
Randy Dotinga
August 29, 2022
B-Cell Lymphoma ICYMI
August 2, 2022

Many die waiting for `last-chance’ therapy

August 2, 2022
Roxanne Nelson, RN, BSN
Roxanne Nelson, RN, BSN
August 2, 2022
ASCO: American Society of Clinical Oncology
B-Cell Lymphoma ICYMI
July 18, 2022

Drug shortages plague hematology, but preparedness helps

July 18, 2022
Randy Dotinga
Randy Dotinga
July 18, 2022
B-Cell Lymphoma ICYMI
June 27, 2022

FDA approves liso-cel as second-line therapy for LBCL

June 27, 2022
Sharon Worcester
Sharon Worcester
June 27, 2022
B-Cell Lymphoma ICYMI
February 3, 2022

EMA gives green light to new CAR T-cell therapy

February 3, 2022
Roxanne Nelson, RN
Roxanne Nelson, RN
February 3, 2022
B-Cell Lymphoma ICYMI
January 21, 2022

100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'

January 21, 2022
Helen Leask, PhD
Helen Leask, PhD
January 21, 2022
B-Cell Lymphoma ICYMI
November 8, 2021

Decades spent searching for genes linked to rare blood cancer

November 8, 2021
Pam Harrison
Pam Harrison
November 8, 2021
B-Cell Lymphoma ICYMI
September 20, 2021

Transfusions, readmissions higher for patients with CLL after cardiac surgery

September 20, 2021
Mark S. Lesney, PhD
Mark S. Lesney, PhD
September 20, 2021
B-Cell Lymphoma ICYMI
Read More

Conference Coverage

February 21, 2023

CML: Preventing chemo-induced vascular toxicity

February 21, 2023
Vincent Richeux
Vincent Richeux
February 21, 2023
B-Cell Lymphoma ICYMI
December 16, 2022

CLL phase 3 study: Zanubrutinib bests ibrutinib

December 16, 2022
Andrew D. Bowser
Andrew D. Bowser
December 16, 2022
ASH: American Society of Hematology
B-Cell Lymphoma ICYMI
December 12, 2022

MCL: Ibrutinib could become the ‘new standard’

December 12, 2022
Randy Dotinga
Randy Dotinga
December 12, 2022
ASH: American Society of Hematology
B-Cell Lymphoma ICYMI
December 7, 2022

ASH 2022: New clinical data challenge long-held assumptions

December 7, 2022
Neil Osterweil
Neil Osterweil
December 7, 2022
ASH: American Society of Hematology
B-Cell Lymphoma ICYMI
August 2, 2022

Many die waiting for `last-chance’ therapy

August 2, 2022
Roxanne Nelson, RN, BSN
Roxanne Nelson, RN, BSN
August 2, 2022
ASCO: American Society of Clinical Oncology
B-Cell Lymphoma ICYMI
June 28, 2022

‘Superior’ CLL regimen cuts chemo in half

June 28, 2022
Nancy A. Melville
Nancy A. Melville
June 28, 2022
B-Cell Lymphoma ICYMI
June 21, 2022

Venetoclax combos prolong progression-free CLL survival

June 21, 2022
Nancy A. Melville
Nancy A. Melville
June 21, 2022
EHA: European Hematology Association
B-Cell Lymphoma ICYMI
June 9, 2022

Novel gene therapy offers hope for some lymphomas

June 9, 2022
Heidi Splete
Heidi Splete
June 9, 2022
ASCO: American Society of Clinical Oncology
B-Cell Lymphoma ICYMI
Read More

Expert Perspective

March 1, 2023

The Evolving Role for Transplantation in Mantle Cell Lymphoma

March 1, 2023
Michael E. Williams, MD, ScM
Michael E. Williams, MD, ScM
March 1, 2023
B-Cell Lymphoma ICYMI
Read More

MD-IQ

B-Cell Lymphoma Subtypes

More

Clinical Edge Journal Scan

No results returned.

Read More

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Menu Presented by
Menu Close
  • Clinical Edge Journal Scan
  • Clinical Topics
  • Conference Coverage
  • Expert Perspectives
  • MD-IQ

More

  • MDedge